PT-141 (Bremelanotide) 10 mg is a high-purity synthetic peptide developed for laboratory and preclinical research focused on melanocortin receptor activity, neurological signaling, and hormone-related pathways. PT-141 is a melanocortin receptor agonist studied for its interaction with MC receptors involved in neuroendocrine function and central nervous system signaling.

In research settings, PT-141 has been used to explore:

• Melanocortin receptor activation: Supports studies on MC3 and MC4 receptor pathways.

• Neurological signaling research: Useful in examining peptide-mediated central nervous system responses.

• Endocrine pathway investigation: Facilitates research on hormone-related signaling mechanisms.

• Behavioral and neuropeptide research: Assists in studying neuropeptide influence on physiological responses.

• Reliable experimental performance: Supplied as lyophilized powder with high analytical purity for reproducibility.

This 10 mg lyophilized formulation ensures stability and precise handling, making it suitable for in vitro assays, receptor binding studies, and preclinical research models.

Applications:

• Melanocortin receptor research

• Neuroendocrine signaling studies

• Peptide receptor binding research

• Central nervous system pathway studies

For research use only. Not intended for human or veterinary consumption.